Adam L Halberstadt
Biographic Data
| ID | 7180847 |
|---|---|
| NAME | Adam L Halberstadt |
| GIVEN NAMES | Adam L |
| FAMILY NAME | Halberstadt |
| SIGNATURE | HALBERSTADT A L |
| AFFILIATIONS | University of California San Diego |
| ORCID | 0000-0001-5096-5829 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 1 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
Behavioral Neurobiology of Psychedelic Drugs
Behavioral Neurobiology of Psychedelic Drugs
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are no published studies, other than case reports, of the effects of cannabis on PTSD symptoms. The purpose of the study was to report and statistically analyze psychometric data on PTSD symptoms collected during 80 psychiatric evaluations of patients applying to the New Mexico Medical Cannabis Program fro…
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
CONTEXT: Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer. OBJECTIVE: To explore the safety and efficacy of psilocybin in patients with advanced-stage cancer…
No prominent works on this page.
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
CONTEXT: Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer. OBJECTIVE: To explore the safety and efficacy of psilocybin in patients with advanced-stage cancer…
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are no published studies, other than case reports, of the effects of cannabis on PTSD symptoms. The purpose of the study was to report and statistically analyze psychometric data on PTSD symptoms collected during 80 psychiatric evaluations of patients applying to the New Mexico Medical Cannabis Program fro…
Behavioral Neurobiology of Psychedelic Drugs
Behavioral Neurobiology of Psychedelic Drugs
Psychology (3 works) · Cannabis and Cannabinoid Research (2 works) · Medicine (2 works) · Psychedelics and Drug Studies (2 works) · Psychiatry (2 works) · Adverse effect (1 work) · Anxiety (1 work) · Beck Anxiety Inventory (1 work) · Beck Depression Inventory (1 work) · Cannabis (1 work)